Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02637349 · ClinicalTrials.gov registry record · Phase 2
Polaris Oncology Survivor Transition (POST) System
A Phase 2 study, sponsored by Polaris Health Directions.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT02637349 is a Phase 2 study that has completed, run by Polaris Health Directions. The registered enrollment target is 200 participants.
The verdict
NCT02637349, a Phase 2 study, has completed, sponsored by Polaris Health Directions.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The POST's public health impact is likely to be substantial because it will improve cancer survivorship planning, which is currently an important deficiency in cancer care recognized by the Institute of Medicine and the American College of Surgeons. The POST may have many potential benefits for patients such as: 1. improved long-term health outcomes; 2. improved psychosocial outcomes and quality of life; 3. smoother transitions back into old and new life roles; and 4. improved continuity and coordination of care between providers. Most importantly, the POST's influence may reach beyond the patients it directly serves as it could help scientists and health care providers understand the potential benefits of cancer survivorship planning and how to best design and implement survivorship planning when patients are ending treatment for cancer.
Interventions
- BEHAVIORAL POST Intervention
- BEHAVIORAL POST Treatment as Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-11-30 |
| Est. Completion | 2019-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02637349
The ClinicalTrials.gov registry entry for NCT02637349 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Polaris Health Directions, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which POST Intervention is the first listed.
NCT02637349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02637349 about?
NCT02637349 is a clinical study titled "Polaris Oncology Survivor Transition (POST) System". The POST's public health impact is likely to be substantial because it will improve cancer survivorship planning, which is currently an important deficiency in cancer care recognized by the Institute of Medicine and the American College of Surgeons. The POST may have many potential benefits for pat...
What is the current status of trial NCT02637349?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2016-11-30. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT02637349?
The interventions under investigation include: POST Intervention (BEHAVIORAL), POST Treatment as Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT02637349?
This trial is sponsored by Polaris Health Directions, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.